Stay Updated
Press Releases
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs is releasing a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package, which weakened […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) filed its sixth patient-centered amicus brief defending the Medicare Negotiation Program, this time in the District of Columbia U.S. Court of Appeals, where Teva Pharmaceuticals is appealing its failed attempt to strike down the program. The brief underscores the real-world impact of lower prices for patients and responds to legal […]
Press Releases
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — A new analysis from Patients For Affordable Drugs spotlights a troubling pattern: pharmaceutical companies are raising prices on HIV medications, while simultaneously lobbying Congress to pass the harmful EPIC Act, which would delay Medicare drug price negotiations that could lower prices on […]
Press Releases
ICYMI: Majority of Americans Worried about Affording Prescription Drugs, New Polling Confirms
WASHINGTON, D.C. — New polling from KFF underscores just how deeply the high cost of prescription drugs is harming Americans across the country. Findings include: 59% of U.S. adults are worried about their ability to pay for prescription drugs, either for themselves or their families. This is the largest share since KFF began polling the question in 2018. […]
Press Releases
Marks the 11th lawsuit filed by Big Pharma and its allies to undermine Medicare Drug Price Negotiation at the expense of patients WASHINGTON, D.C. — Just two weeks after Botox and Botox Cosmetic were named as drugs to be included in the third round of Medicare Drug Price Negotiations, manufacturer AbbVie, has filed a lawsuit in the U.S. District Court […]
Press Releases
STATEMENT: CMS Announces 15 Drugs Selected for Round 3 of Medicare Drug Price Negotiation
Drugs included in Round 3 are used by nearly 1.8 million people on Medicare and accounted for $27 billion in Medicare spending WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has released the list of the next 15 high-priced medications selected for Medicare Drug Price Negotiation, along with one drug selected for […]
Press Releases
Remembering David Mitchell: A Distinguished Life In Service to Others
WASHINGTON, D.C. — Today, we honor the life, legacy, and friendship of David Mitchell – a tireless public health leader and the founder of Patients For Affordable Drugs – who died on Friday, January 2, 2026. Below is a statement from Chuck Hurley, David’s great friend and Board Chair of Patients For Affordable Drugs, reflecting on […]
Press Releases
WASHINGTON, D.C. — The Solicitor General’s office filed a brief urging the Supreme Court to deny AstraZeneca’s petition challenging the constitutionality of the Medicare Negotiation Program, forcefully defending the program and rejecting the drugmaker’s claims outright. The filing responds to AstraZeneca’s effort to overturn a 2024 appeals court ruling that upheld the program. The petition […]